Cracking Open the Old Warning “Internal Diseases Do Not Treat Asthma”: The Lungs May Not Be Damaged — The Problem Could Be Stuck in the Cervical Spine — An Overlooked “Signal Attenuation” Perspective

“Internal diseases do not treat asthma; external diseases do not treat tinea.” This old saying has been passed down in Chinese medicine for generations — not because doctors refuse to treat asthma, but because asthma is stubborn and prone to recurrence. In China, the prevalence of asthma among people aged 20 and above is approximately 4.2%, totaling about 45.7 million, with allergic asthma accounting for over 60% of adult cases. Behind these numbers lies a disease that has long been approached as a problem “inside the lungs themselves.”But there is an angle that has rarely been placed squarely on the table: the lungs may not have suffered substantive damage at all. What is actually failing could be the “signal pathway” between the brain and the lungs — pinched at the cervical spine.

What the Conventional Understanding of Asthma Leaves Out

Modern medicine’s core understanding of asthma centers on chronic airway inflammation and airway hyperresponsiveness. This framework explains a great deal and has produced effective tools such as inhaled corticosteroids and bronchodilators. But it carries an implicit premise: the problem is primarily “in the lungs.”

Clinically, there is another category of phenomena that has long been relegated to “rare” or “indirectly related”: malalignment or soft tissue injury at the C4–C7 and T1 levels may irritate the sympathetic nerves, weakening sympathetic inhibition of the bronchi and relatively enhancing parasympathetic activity, thereby triggering bronchial smooth muscle spasm and increased secretions. Medical literature has a specific term for this — “spondylogenic asthma” or “cervicothoracic spondylogenic asthma” — in which deformation, malalignment, or soft tissue injury of the lower cervical and upper thoracic spine stimulates or compresses the visceral nerves supplying the lungs and trachea, causing airway spasm and breathing difficulty. International literature has also documented cases in which the phrenic nerve is involved at the cervical level, affecting diaphragmatic function and aggravating respiratory symptoms.

Most of these studies are carefully worded and do not claim that “cervical spondylosis directly causes asthma.” But read together, they point to a position that mainstream narratives have kept at the margins: the cervical spine may be a “chokepoint” in the signal transmission between the brain and the lungs.

A Metaphor: Why Does 5G Drop to 2G?

For the brain to direct the lungs to function properly, two routes must remain open simultaneously: the neural electrical signal, traveling down through the spinal cord and cervicothoracic nerve pathways; and the nourishing route of qi, blood, and body fluids, percolating through the meridian and fascial systems.

The cervical spine happens to be the densest “interchange station” where these two routes converge. Prolonged forward head posture, overuse, accumulated cold-damp, and fascial adhesion first create congestion at this interchange. Neural signals do not disappear because of congestion — they attenuate. It is like a 5G base station with a full signal, but the transmission node in between is pinched; what arrives at the terminal is only 2G. The instructions the lungs receive are blurred, intermittent, and insufficient in intensity. The lungs are still working, but the precision of “repair instructions” and “regulatory instructions” has declined. Airway hyperresponsiveness, spasm tendency, and dysregulation of secretions are more easily maintained in this state of “signal downgrade.”

The significance of this perspective is that it does not deny the inflammation in the lungs, but it redirects the question of “why does inflammation recur and why is control unstable” to an upstream node: the cervical spine.

Feishu (BL13): A Point Watched by Both Ancient Physicians and Modern Research

Acupoint selection in Chinese medicine is never arbitrary. Feishu (BL13) is located 1.5 cun lateral to the lower border of the spinous process of the third thoracic vertebra — just below the cervicothoracic junction. The ancient text Shi Fang Miao Yong already described asthma as “cold pathogen lurking at Feishu,” identifying this point as a key site where pathogenic factors entrench themselves.

Modern research has repeatedly touched this same location. Clinical studies have systematically evaluated the asthma-relieving effect of electroacupuncture at Feishu during acute bronchial asthma attacks; studies on moxibustion at Feishu in asthma model rats have shown that stimulating this area can influence indicators of airway inflammation. Heat-sensitive moxibustion research further found that in patients with chronic persistent asthma, heat-sensitive acupoints cluster predominantly along the Dazhui (GV14), Zhiyang (GV9), and Feishu line — precisely corresponding to the cervicothoracic spine.

In other words, Feishu is not an isolated “switch”; it is a key node on the cervicothoracic signal pathway. Congestion here does not necessarily mean “the lungs themselves are sick” — it more likely means “the signal traveling to the lungs has been shaved down at this checkpoint.”

Where Qitong Therapy Enters: Not Aimed at “Treating Asthma,” but at the “Pathway”

Placed within this framework, the rationale for applying Qitong therapy to asthma becomes clearer. It does not follow the route of “oral medication — gastrointestinal absorption — blood circulation — arrival at the lungs.” It enters directly through the skin and meridians.

Medicinal vapor formed in a high-temperature chamber first opens the sweating method layer: pores dilate, cold-damp and metabolic waste are discharged with sweat, and the “turbidity” between the body surface and muscle layers is loosened first. Then comes warming and unblocking: high-temperature medicinal vapor acts continuously on the cervicothoracic spine; the heat itself relieves spasm, while the medicinal properties penetrate with the thermal force, gradually dissolving fascial adhesion, cold-damp condensation, and stasis at the cervicothoracic junction. Discharging turbidity and warming-unblocking are two sides of the same process: what is discharged is the material blocking the road; what is warmed and unblocked is the condition that restores the road’s own elasticity.

The region where Feishu is located is precisely the area that Qitong therapy covers in the cervicothoracic segment. Dissolving congestion here is not about “repairing the lungs” directly — it is about re-widening the attenuated signal pathway between the brain and the lungs. When the compression at the cervical chokepoint is reduced and the “bandwidth” of neural signaling and qi-blood nourishment is restored, the instructions the lungs receive become clear again, and the lungs’ own regulatory and reparative capacity has the conditions to return to order. The 3-to-5-course treatment cycle corresponds not to “the lungs being cured,” but to the rhythm of the pathway being loosened layer by layer.

This also explains why this perspective deserves serious consideration for some people whose asthma remains poorly controlled despite treatment, yet in whom no severe structural damage to the lungs themselves can be found. The lungs are not broken. What is broken is the “line” between them and the brain.

Not a Conclusion, but a Direction Worth Taking Seriously

It must be stated clearly: spondylogenic asthma accounts for only a small proportion of all asthma, and the relationship between the cervical spine and asthma is still regarded in mainstream medicine as “indirectly associated” rather than “directly causal”. Qitong therapy is not a “miracle asthma cure”; it is a pathway-repair approach within Chinese medicine’s external treatments, and whether it is appropriate for a given person can only be determined after a physician’s in-person assessment of cervical status, asthma type, and overall condition.

But the reason “internal diseases do not treat asthma” became an old warning is precisely that past approaches mostly focused on the lungs alone. When a disease is treated repeatedly and recurs repeatedly, looking at the problem through a different entry point is itself a perspective worth allowing. The “root” of asthma may not be in the lungs, but on the road leading to them. This direction deserves more rigorous verification and cautious discussion — not dismissal at the door with a single word: “impossible.”